Skip to content
GLP-1 Desk
Menu
Dispatch #13Editorial

RxSpan MD

The widest access profile of the new batch — brand, compounded, oral, injectable, all 50 states — at a premium price.

Visit RxSpan MDEditorial — no commercial relationship.
Semaglutide
$249/mo
Tirzepatide
$329/mo
Coverage
All 50 states
Brand-name
Yes

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency76/100
State access96/100
Molecule range94/100
Onboarding speed82/100
Support responsiveness82/100
Licensing & trust90/100

What the Desk likes

  • Brand and compounded access on both molecules
  • Oral and injectable routes available
  • Nationwide 50-state coverage

Where points come off

  • Premium pricing on both molecules
  • Newer brand

The Desk's briefing — B

Best for: Patients who want every route and format on the table and will pay for the breadth.

RxSpan MD ranks #13 of 25 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Pricing and verification reflect RxSpan MD's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on RxSpan MD's site. Not medical advice; see our disclosure.

← Back to The Desk